Replay available

Perimeter Medical Imaging AI, Inc. (PINK) Q1 2026 Earnings Call

Perimeter Medical Imaging AI, Inc. (TSXV: PINK) Q1 2026 earnings conference call, held 2026-05-28. Replay captured from the company's public earnings webcast.

Thu, May 28, 2026 at 5:00 PMendedReplay
Perimeter Medical Imaging AI, Inc. (PINK) Q1 2026 Earnings Call

Hosted by

Featured presenters

Stephen Kilmer

Investor Relations

Sarah Bryan

Chief Financial Officer

Abby Goodman

Vice President of Sales

Adrian Mendez

Chief Executive Officer

Scott McCauley

Analyst, Paradigm Capital

Michael Freeman

Analyst, Raymond James

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Perimeter Medical Imaging Ai Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.520 Good afternoon, ladies and gentlemen, and welcome to Perimeter Medical Q1 2026 conference 00:00:05.520 -- 00:00:09.045 call. At this time, all lines are in a listen-only mode. 00:00:09.045 -- 00:00:12.291 Following the presentation, we will conduct a question-and-answer session. 00:00:12.291 -- 00:00:17.479 If at any time during this call you require immediate assistance, please press star zero 00:00:17.479 -- 00:00:22.166 for the operator. This call is being recorded on Thursday, May 28, 2026. 00:00:22.166 -- 00:00:26.994 I would now like to turn the conference over to Stephen Kilmer, Investor Relations. 00:00:26.994 -- 00:00:29.258 Please go ahead. 00:00:29.258 -- 00:00:33.706 Thank you. Good afternoon, everyone. Let me start by pointing out that this conference 00:00:33.706 -- 00:00:37.994 call will include forward-looking statements within the meaning of applicable securities 00:00:37.994 -- 00:00:42.682 laws. These may include statements regarding the future financial position, business 00:00:42.682 -- 00:00:47.591 strategy and strategic goals, commercial activities and timing, competitive conditions, 00:00:47.591 -- 00:00:52.139 research and development activities, projected costs and capital expenditures, research 00:00:52.139 -- 00:00:57.044 and clinical testing outcomes, The potential benefits of our products, including Perimeter 00:00:57.044 -- 00:01:02.330 S Series, OCT, and CLAIRE, formerly Perimeter B Series, OCT, Perimeter's 00:01:02.330 -- 00:01:07.377 ability to broaden its user base and system utilization, expectations regarding 00:01:07.377 -- 00:01:11.802 new products and the timing thereof, and expectations regarding opportunities for market 00:01:11.802 -- 00:01:13.424 expansion. 00:01:13.424 -- 00:01:16.868 Fo...